DCF — DOYLESTOWN HOSPITAL
Enterprise Value: $-493.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-493.8M
Enterprise Value
$-156.8M
PV of Cash Flows
$-337.0M
PV of Terminal Value
$-542.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $326.7M | $-30.4M | -9.0% | $-44.3M | $-40.2M |
| Year 2 | $336.5M | $-28.0M | -8.0% | $-42.2M | $-34.9M |
| Year 3 | $346.5M | $-25.4M | -7.0% | $-40.0M | $-30.1M |
| Year 4 | $356.9M | $-24.3M | -7.0% | $-39.4M | $-26.9M |
| Year 5 | $367.6M | $-24.1M | -7.0% | $-39.7M | $-24.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-493.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$317.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09818259968313967
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5